PlainPharmaWatch

CMS Open Payments · Program Year 2024

Elevation Spine, Inc.

Elevation Spine, Inc. reported $38,622.81 across General Payments, Research, and Ownership to 152 physicians and teaching hospitals across 152 transactions.

$38.6K
All-tracks total
152
Transactions
152
Recipients
−$6.7K
General Payments vs PY2023

Elevation Spine, Inc. reported $38,622.81 across all CMS Open Payments tracks (General + Research + Ownership) to 152 physicians and teaching hospitals in Program Year 2024 - ranking #1413 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $38,622.81, averaging $254.10 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer elevation-spine-inc Elevation Spine, Inc.

$38.6K · #1413/1,925 · 0.0% industry · PY2024

  • TOT $38.6K
  • RANK #1413
  • SHARE 0.0%
  • TXN 152
  • RCP 152
  • CAT 2
  • GEN $38.6K
  • ΔGEN −$6.7K
  • TOP1 17.5%
  • PY 2024

Nearest volume peer: OVIK Health, LLC ($38.7K)

Polaris Technology Solutions…$39.0KParaPRO, LLC$38.8KOVIK Health, LLC$38.7KElevation Spine, Inc. (this)$38.6KArcuro Medical Inc$38.4K
All-tracks payment totals near Elevation Spine, Inc. (CMS Open Payments PY2024)

Elevation Spine, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Elevation Spine, Inc.'s CMS-reported General Payments decreased by $6.7K (−14.7%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: ELEVATION SPINE, INC.PY2024: Elevation Spine, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$45.3KPY2024$38.6K
PY2023
$45,303.10
PY2024
$38,622.81

What the Data Shows for Elevation Spine, Inc.

Elevation Spine, Inc. ranks #1413 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $38,622.81 across 152 transactions to 152 physicians and teaching hospitals - $254.10 per transaction and $254.10 per recipient on average.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $32.5K across 47 transactions, 84.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Elevation Spine, Inc.'s 2-category general-payment breakdown at $32.5K, 84.2% of the reported total.

How Elevation Spine, Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$32.5K2. Food and Beverage$6.1K
Payment Type Amount Transactions
Consulting Fee $32.5K 47
Food and Beverage $6.1K 105

Recipient Concentration in General Payments

The five largest recipient relationships account for $21,380.43 (55.4%) of $38,622.81 in this company's General Payments records across 100 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Elevation Spine, Inc.

The five named recipients with the highest reported General Payments from this company

Lauren E Matteini$6.7KAlejandro D Castellvi$4.0KJoseph M Graham$4.0KVikram Mehta$3.5KK B Strenge$3.1K
  1. 1

    Lauren E Matteini

    $6,749.14 across 6 reported transactions

  2. 2

    Alejandro D Castellvi

    $4,000.00 across 8 reported transactions

  3. 3

    Joseph M Graham

    $4,000.00 across 8 reported transactions

  4. 4

    Vikram Mehta

    $3,500.00 across 7 reported transactions

  5. 5

    K B Strenge

    $3,131.29 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Elevation Spine, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Elevation Spine, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Elevation Spine, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Elevation Spine, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.